On September 21, 2017, Stanley Yarbro announced that on August 10, 2017, he has presented a notice of stockholder proposal to nominate directors for election at Calmare Therapeutics Incorporated’s annual meeting in accordance with the Company’s By-laws proposing for nomination a slate of 5 individuals: Stanley Yarbro, Vice Admiral Robert T. Conway, Steve Roehrich, Robert Davis, and Benjamin Large to serve as directors of the Company.